Bank Pictet & Cie Europe AG Has $3.33 Million Stake in Cigna Group $CI

Bank Pictet & Cie Europe AG decreased its holdings in Cigna Group (NYSE:CI) by 19.2% in the 3rd quarter, HoldingsChannel reports. The firm owned 11,567 shares of the health services provider’s stock after selling 2,742 shares during the quarter. Bank Pictet & Cie Europe AG’s holdings in Cigna Group were worth $3,334,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in CI. Flaharty Asset Management LLC bought a new position in shares of Cigna Group in the first quarter valued at about $28,000. Solstein Capital LLC bought a new stake in Cigna Group during the 2nd quarter worth about $29,000. Harbor Capital Advisors Inc. increased its position in Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 49 shares in the last quarter. Chilton Capital Management LLC acquired a new stake in Cigna Group in the 2nd quarter valued at about $30,000. Finally, Princeton Global Asset Management LLC raised its stake in shares of Cigna Group by 115.6% in the second quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock worth $32,000 after acquiring an additional 52 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Activity at Cigna Group

In related news, CEO David Cordani purchased 4,134 shares of the stock in a transaction dated Monday, November 3rd. The stock was bought at an average cost of $241.88 per share, with a total value of $999,931.92. Following the purchase, the chief executive officer directly owned 157,935 shares in the company, valued at $38,201,317.80. The trade was a 2.69% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.70% of the stock is currently owned by company insiders.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $275.06 on Friday. The firm has a fifty day moving average of $272.75 and a two-hundred day moving average of $290.49. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76. The stock has a market capitalization of $73.48 billion, a price-to-earnings ratio of 12.13, a PEG ratio of 1.00 and a beta of 0.26. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. The business had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The firm’s revenue was up 9.5% on a year-over-year basis. During the same period last year, the company earned $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities research analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th were given a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Thursday, December 4th. Cigna Group’s payout ratio is presently 26.64%.

Wall Street Analyst Weigh In

CI has been the subject of a number of research reports. The Goldman Sachs Group lowered their price target on shares of Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a report on Tuesday, November 4th. Truist Financial decreased their price objective on Cigna Group from $375.00 to $310.00 in a research report on Friday, October 31st. Barclays lowered their target price on Cigna Group from $383.00 to $300.00 and set an “overweight” rating for the company in a research note on Friday, October 31st. Guggenheim reaffirmed a “buy” rating and set a $318.00 price target on shares of Cigna Group in a research note on Tuesday, December 2nd. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Cigna Group in a report on Monday. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $331.83.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.